Lv4
570 积分 2025-03-19 加入
Unravelling the role of Interleukin-12 in Neuroinflammatory mechanisms: Pathogenic pathways linking Neuroinflammation to neuropsychiatric disorders
2天前
已完结
Unravelling the role of Interleukin-12 in Neuroinflammatory mechanisms: Pathogenic pathways linking Neuroinflammation to neuropsychiatric disorders
2天前
已关闭
Better efficacy, lower recurrence rate and decreased CD8+TRM with guselkumab treatment for generalized pustular psoriasis: A prospective cohort study from China
4天前
已完结
Treatment of multiple sclerosis — success from bench to bedside
8天前
已完结
Ocrelizumab versus Placebo in Primary Progressive Multiple Sclerosis
8天前
已完结
Safety and efficacy of the selective sphingosine 1-phosphate receptor modulator ozanimod in relapsing multiple sclerosis (RADIANCE): a randomised, placebo-controlled, phase 2 trial
16天前
已完结
A Pilot Trial of Cop 1 in Exacerbating–Remitting Multiple Sclerosis
16天前
已完结
Efficacy and safety of oral fumarate in patients with relapsing-remitting multiple sclerosis: a multicentre, randomised, double-blind, placebo-controlled phase IIb study
16天前
已完结
Siponimod for patients with relapsing-remitting multiple sclerosis (BOLD): an adaptive, dose-ranging, randomised, phase 2 study
16天前
已完结
Oral Fingolimod (FTY720) for Relapsing Multiple Sclerosis
16天前
已完结
皖公网安备34019202002308
